Evidence map›Paper›PMID 29434881›Full record

ArticleOncology letters2018

Peiliang Zhang, Zengyun Li, Dongqing Wang, Fuling Ma, Ran Zhang, Wanhua Liang, Mingping Sun, Zheng Fu, Xiaorong Sun

Open access · diamondAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Oncology letters, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.5field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 6 citations in OpenAlex.

  1. Predictive value of clinical andScientific reports · 2022
    Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 1 country.

Peiliang ZhangDepartment of Radiation Oncology, Linyi Central Hospital, Yishui, Linyi, Shandong 276400, P.R. China.
Zengyun LiDepartment of Oncology, Laiwu Municipal Hospital of Traditional Chinese Medicine, Laiwu, Shandong 271100, P.R. China.
Dongqing WangDepartment of Radiation Oncology, Shandong Tumor Hospital, Jinan, Shandong 250117, P.R. China.
Fuling MaDepartment of Radiation Oncology, Linyi Central Hospital, Yishui, Linyi, Shandong 276400, P.R. China.
Ran ZhangDepartment of Radiation Oncology, Linyi Central Hospital, Yishui, Linyi, Shandong 276400, P.R. China.
Wanhua LiangDepartment of Radiation Oncology, Linyi Central Hospital, Yishui, Linyi, Shandong 276400, P.R. China.
Mingping SunDepartment of Radiation Oncology, Shandong Tumor Hospital, Jinan, Shandong 250117, P.R. China.
Zheng FuDepartment of Nuclear Medicine, Shandong Tumor Hospital, Jinan, Shandong 250117, P.R. China.
Xiaorong SunDepartment of Nuclear Medicine, Shandong Tumor Hospital, Jinan, Shandong 250117, P.R. China.
Linyi People's Hospital · CNShandong First Medical University · CNShandong Tumor Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The aim of the present study was to explore the value of

Indexed as

chemoradiotherapyesophageal squamous cell carcinomapositron emission computed tomographyresponse

Identifiers

PMID29434881
PMCPMC5776923
OpenAlexW2771532753

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.